Duke CFAR Microgrants
The CFAR Developmental Core Microgrants are one year awards that are intended to facilitate HIV/AIDS research by providing modest, but essential, resources that are not readily available from other sources. The Microgrant program is designed to support new NIH grant applications that will increase the HIV/AIDS funded research base at Duke.
Microgrant Awards are up to $20K for a 1 year award and are available throughout the year.
CFAR Microgrants of up to $20,000 will now be available on an ad hoc basis throughout the year. These one year awards are intended to facilitate HIV/AIDS research by providing modest, but essential, resources that are not readily available from other sources. The Microgrant program is designed to support new NIH grant applications that will increase the HIV/AIDS funded research base at Duke.
Microgrant Awards should be used for
- Generating preliminary data for planned HIV/AIDS-related NIH grant applications with review by CFAR leadership. (Target RFA/FOA(s) required)
- Bridge funding for generating preliminary data to address a weakness for HIV/AIDS-related NIH R grants that received scores, but were not funded. (Summary statement required)
- Performance of specific experiments requested by manuscript reviewers. Must be HIV/AIDS-related. (Manuscript review required)
Scope
Funds may be used for any HIV/AIDS research-related purpose, including salary/wages (e.g. temporary employee to assist in data collection or analysis), consultant costs, and supplies, or study subject incentives.
Eligibility
- Post-doctoral and Clinical Fellows. (Must show path to independent funding)
- Duke faculty (Priority given to Early Stage Investigators)
- Mid and Senior level investigators new to HIV research
- Applicants with a current K award must have NIH pre-approval
- Senior HIV investigators are rarely eligible and must have NIH pre-approval
- Funding is restricted to activities within the United States.
- Must have PI status prior to submitting an application*
*Any individuals that are not regular rank faculty (e.g., residents, post-docs, research scientists, non-regular rank faculty) and have an ongoing employment relationship with the University, may be approved to serve as a PI/PD on applications for external funding through the PI Eligibility request form.
Application
The application will be reviewed by an internal CFAR Committee. Turnaround time is < 1 month. Please email the completed application, along with your summary statement or manuscript review (if applicable) to Microgr.2y6jv7ecppq52ohn@u.box.com
Once you receive confirmation that your file was uploaded, please email cfar-dev-core@duke.edu to start the review process.
Duke CFAR Pilot Awards
The CFAR Developmental Core Pilot Awards support scientific studies for 1 year. The purpose of these awards is to develop preliminary data for peer-reviewed applications.
Proposals must target one of the NIH HIV/AIDS Priority Areas of Research.
Two types of Pilot Awards are available
- Standard Pilot Awards (7 pages) -- up to a maximum award of $100,000 direct funding
- Focused Pilot Awards (3 pages) -- up to a maximum award of $60,000 direct funding
Eligibility for CFAR Pilot Grant Awards
Faculty
- No prior R01 level funding in the HIV/AIDS field
- Applicants with prior R01 funding in other fields are encouraged to apply
Post-doctoral and Clinical fellows
- Applicants with a current K award must have NIH pre-approval
- T32 awardees cannot use CFAR award for training or stipends
- Separate letter of support from faculty mentor required, see Application information below
- PI Status must be submitted and obtained by department and approval document must be included in your CFAR pilot application.
*Questions on eligibility should be directed to the CFAR Developmental Core
CFAR Supplements
The Duke CFAR investigators have had great success in receiving CFAR supplements across a broad number of disciplines and NIH institutes, including National Institute of Nursing Research and National Institute of Dental and Craniofacial Research, among others. These supplements are summarized in the Highlight Box below.
Ending the HIV Epidemic (EHE)
| Investigator (Year) | EHE Supplement Grant Title |
|---|---|
| Meredith Clement/Amy Corneli 2019 | Getting to [NO]one in New Orleans: Enhancing PrEP Uptake in Black Women to End the Epidemic |
| Amy Corneli 2019 | PrEP-MECK: Identifying community-driven approaches for Increasing PrEP uptake, adherence, and persistence among Black men who have sex with men in Mecklenburg County, North Carolina |
| Amy Corneli 2020 | PrEP-MECK: Increasing PrEP uptake among Same Gender Loving Men in Mecklenburg County, North Carolina |
| Amy Corneli 2021 | EHE: Preparing for implementation of strategies to promote uptake of long-acting injectable PrEP among Black same gender loving men in HBCU communities |
| Sadie Wilson 2022 | Equity-focused implementation mapping to improve PrEP uptake and maintenance among Latines (Sub Site Latino AIDS Commission) |
| Lauren Brinkley Rubinstein 2023 | Evaluating the use of long-acting antiretroviral treatment for HIV during community re-entry: Addressing community and structural barriers |
| Charles Burns 2023 | Leveraging Southern Community-Based Pharmacies for PrEP Referrals |